Design, synthesis and antiviral activity of new pyridinone derivatives

Antiviral Chemistry and Chemotherapy

Volumn 8, Issue 2, 1997, Pages 161-172

  Jourdan, F ^a   Renault, J ^a   Fossey, C ^a   Bureau, R ^a   Laduree D ^a   Robba, M ^a   Aubertin, A M ^b   Kirn, A ^b  

^a CENTRE D ETUDES ET DE RECHERCHE SUR LE MÉDICAMENT DE NORMANDIE   (France)

^b INSERM   (France)

Author keywords

3 (arylmethyl)oxy methyl pyridin 2 ones; EBPU; HIV 1; L 696,229; reverse transcriptase

Indexed keywords

3 [2 (2 BENZOXAZOLYL)ETHYL] 5 ETHYL 6 METHYL 2(1H) PYRIDONE; DIPYRONE; EBDU; PYRIDONE DERIVATIVE; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; DRUG DESIGN; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL;

EID: 0031049742     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029700800210     Document Type: Article

References (30)

1. 50, synergism, antagonism, low-dose risk, receptor binding and enzyme kinetics. Computer software for Apple II Series and IBM-PC and instruction manual. Cambridge: Elsevier-Biosoft, pp. 19-28.
2. Clark M, Cramer III RD & Van Opdenbosh N (1989) Validation of the general purpose Tripos 5.2 force field. Journal of Computational Chemistry 10: 982-1012.
3. Clark M, Cramer III RD, Jones DM, Patterson DE & Simperath PE (1990) Comparative molecular field analysis. 2. Toward its use with 3D structural databases. Tetrahedron Computer Methodology 3: 47.
4. Cramer III RD, Patterson DE & Brunce JD (1988) Comparative molecular field analysis. 1. Effect of shape on binding of steroids to proteins. Journal of the American Chemical Society 110: 5959.
5. Debyser Z, Pauwels R, Andries K, Desmyter J, Kukla M, Janssen PAJ & De Clercq E (1991) An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo[4,5,1-jk] [1,4] benzodiazepin-2 (1H)-one and thione derivatives. Proceedings of the National Academy of Sciences, USA 88: 1451-1455.
6. Dournon E, Matheson S, Rosenbaum W, Ghanakhanian S, Michow C, Girard PM, Pezzonne C, Salmon D, De Truchio P, Lepost C, Bouvet E, Dazza MC, Le Vacher M, Regnier B & the Claude Bernard Hospital AZT Study Group (1988) Effects of zidovudine in 365 consecutive patients with AIDS or AIDS related complex. Lancet i: 1297-1302.
7. Gasteiger J & Marsili M (1980) Iterative partial equalization of orbital electronegativity - a rapid access to atomic charges. Tetrahedron 36: 3219-3228.
8. Hoffman JM, Wai JS, Thomas CM, Levin RB, O'Brien JA & Goldman ME (1992) Synthesis and evaluation of 2-pyridinone derivatives as HIV-1 specific reverse transcriptase inhibitors. 1. Phtalimidoalkyl and alkylamino analogues. Journal of Medicinal Chemistry 35: 3784-3791.
9. Hoffman JM, Smith AM, Rooney CS, Fisher TE, Wai JS, Thomas CM, Bamberger DL, Barnes JL, Williams TM, Jones JH, Olson BD, O'Brien JA, Goldman ME, Nunberg JH, Quintero JC, Schleif WA, Emini EA & Anderson PS (1993) Synthesis and evaluation of 2-pyridinone derivatives as HIV-1 specific reverse transcriptase inhibitors. 4. 3-[2-(benzoxazol-2-yl)ethyl]-5-ethyl-6-methylpyridin-2 (1H)-one and analogues. Journal of Medicinal Chemistry 36: 953-966.
10. Koup RA, Merluzzi VJ, Hargrave KD, Adams J, Grozinger K, Eckner RJ & Sullivan JL (1991) Inhibition of human immunodeficiency virus type 1 (HIV-1) replication by a dipyridodiazepinone (BI-RG-587). Journal of Infectious Diseases 163: 966-970.
11. Lambert JS, Seidlin M, Reichmen RC, Plank CS, Laverty M, Morse GD, Knupp C, McLaren C, Pettinelli C, Valentine FT & Dolin R (1990) 2′,3′-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. New England Journal of Medicine 324: 1412-1416.
12. Mellors JW, Durschman GE, Im GJ, Tramontano E, Winkler SR & Cheng YC (1991) In vitro selection and molecular characterization of human immunodeficiency virus-1 resistant to non-nucleoside inhibitors of reverse transcriptase. Molecular Pharmacology 41: 446-451.
13. Merluzzi VJ, Hargrave KD, Labadia M, Grozinger K, Skoog M, Wu JC, Shih C-K, Eckner K, Hattox S, Adams J, Rosenthal AS, Faanes R, Eckner RJ, Koop RA & Sullivan JL (1990) Inhibition of HIV-1 replication by a non-nucleoside reverse transcriptase inhibitor. Science 250: 1411-1413.
14. Mitsuya H, Yarchoan R & Broder S (1990) Molecular targets for AIDS therapy. Science 249: 1533-1544.
15. Moog C, Wick A, Le Ber P, Kirn A & Aubertin AM (1994) Bicyclic imidazo derivatives, a new class of highly selective inhibitors for the human immunodeficency virus type 1. Antiviral Research 24: 275-288.
16. Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. Journal of Immunological Methods 65: 55-63.
17. Paine JB (1987) A convenient synthesis of nicotinate esters from 3-cyanopyridinones. Journal of Heterocyclic Chemistry 24: 351-355.
18. Pauwels R, Andries K, Desmyter J, Schols D, Kukla M-J, Breslin HJ, Raeymaeckers A, Van Gelder J, Woestenborghs R, Heykants J, Schellekens H, Janssen MAC, De Clercq E & Janssen PAJ (1990) Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives. Nature 343: 470-474.
19. Pauwels R, Andries K, Debyser Z, Van Daele P, Schols D, Stoffels P, De Vreese K, Woestenborghs R, Vandamme A-M, Janssen CGM, Anné J, Cauwenbergh G, Desmyter J, Heykants J, Janssen MAC, De Clercq E & Janssen PAJ (1993) Potent and highly selective human immunodeficiency virus type 1 (HIV-1) inhibition by a series of a-anilinophenylacetamide derivatives targeted at HIV-1 reverse transcriptase. Proceedings of the National Academy of Sciences, USA 90: 1711-1715.
20. Richman DD, Fischl MA, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, Leedom JM, Groopman JE, Mildvan D, Hirsch MS, Jackson GG, Durack DT, Nusinoff-Lehrman S & The AZT Collaborative Working Group (1987) The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS related complex. New England Journal of Medicine 317: 192-197.
21. Romero DL, Busso M, Tan C-K, Reusser F, Palmer JR, Poppe SM, Aristoff PA, Downey KM, So AG, Resnick L & Tarpley WG (1991) Non-nucleoside reverse transcriptase inhibitors that potently and specifically block human immunodeficiency virus type 1 replication. Proceedings of the National Academy of Sciences, USA 88: 8806-8810.
22. Romero DL, Morge RA, Genin MJ, Biles C, Busso M, Resnick L, Althaus IW, Reusser F, Thomas RC & Tarpley WG (1993) Bis(heteroaryl)piperazine (BHAP) reverse transcriptase inhibitors: structure-activity relationships of novel substituted indole analogues and the identification of 1-[(5-methanesulfonamide-1H-indol-2-yl)carbonyl)]-4-[3-(1-methylethyl)amino] pyridinyl piperazine monomethane-sulfonate (U-90152s). Journal of Medicinal Chemistry 36: 1505-1508.
23. Saari WS, Hoffman JM, Wai JS, Fisher TE, Rooney CS, Smith AM, Thomas CM, Goldman ME, O'Brien JA, Nunberg JH, Quintero JC, Schleif WA, Emini EA, Stern AM & Anderson PS (1991) 2-pyridinone derivatives: a new class of nonnucleoside, HIV-1-specific reverse transcriptase inhibitors. Journal of Medicinal Chemistry 34: 2922-2925.
24. Saari WS, Wai JS, Fisher TE, Thomas CM, Hoffman JM, Rooney CS, Smith AM, Jones JH, Bamberger DL, Goldman ME, O'Brien JA, Nunberg JH, Quintero JC, Schleif WA, Emini EA & Anderson PS (1992) Synthesis and evaluation of 2-pyridinone derivatives as HIV-1 specific reverse transcriptase inhibitors. 2. Analogues of 3-aminopyridin-2 (1H)-one. Journal of Medicinal Chemistry 35: 3792-3802.
25. Saunders M, Houk KN, Wu Y-D, Clark Still W, Lipton M, Chang G and Guida WC (1990) Conformations of cycloheptadecane. A comparison of methods for conformational searching. Journal of the American Chemical Society 112: 1419-1427.
26. Tanaka H, Baba M, Hayakawa H, Sakamaki T, Miyasaka T, Ubasawa M, Takashima H, Sekiya K, Nitta I, Shigeta S, Walker RT, Balzarini J & De Clercq E (1991a) A new class of HIV-1-specific 6-substituted acyclouridine derivatives: synthesis and anti HIV-1 activity of 5-or 6-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). Journal of Medicinal Chemistry 34: 349-357.
27. Tanaka H, Baba M, Ubasawa M, Takashima H, Sekiya K, Nitta I, Shigeta S, Walker RT, De Clercq E & Miyasaka T (1991b) Synthesis and anti HIV activity of 2-, 3-and 4-substituted analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT). Journal of Medicinal Chemistry 34: 1394-1399.
28. Vinter JG, Davis A & Saunders MR (1987) Strategic approaches to drug design. I. An integrated software framework for molecular modelling. Journal of Computer-Aided Molecule Design 1: 31.
29. Wai JS, Williams TM, Bamberger DL, Fisher TE, Hoffman JM, Hudcosky RJ, MacTough SC, Rooney CS, Saari WS, Thomas CM, Goldman ME, O'Brien JA, Emini EA, Nunberg JH, Quintero JC, Schleif WA & Anderson PS (1993) Synthesis and evaluation of 2-pyridinone derivatives as HIV-1 specific reverse transcriptase inhibitors. 3. Pyridyl and phenyl analogs of 3-aminopyridin-(1H)-one. Journal of Medicinal Chemistry 36: 249-255.
30. Yarchoan R, Mitsuya H, Myers CE & Broder S (1989) Clinical pharmacology of 3′-azido-2′,3′-dideoxythymidine (zidovudine) and related dideoxynucleosides. New England Journal of Medicine 321: 726-738.